Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 127.65 USD -0.07% Market Closed
Market Cap: 7.9B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Wall Street
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 182.28 USD with a low forecast of 121.2 USD and a high forecast of 241.5 USD.

Lowest
Price Target
121.2 USD
5% Downside
Average
Price Target
182.28 USD
43% Upside
Highest
Price Target
241.5 USD
89% Upside

JAZZ Last Price Targets
Jazz Pharmaceuticals PLC

The latest public price target was made on Oct 23, 2024 by Daniel Busb from RBC Capital , who expects JAZZ stock to rise by 40% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Daniel Busb
RBC Capital
179 USD
Upside 40%
3 weeks ago
Oct 23, 2024
Jazz Pharmaceuticals (JAZZ) PT Raised to $179 at RBC Capital
StreetInsider
Annabel Samimy
Stifel Nicolaus
230 USD
Upside 80%
2 months ago
Sep 11, 2024
Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
StreetInsider
Andrea Tan
Goldman Sachs
169 USD
Upside 32%
5 months ago
Jun 5, 2024
Goldman Sachs Starts Jazz Pharmaceuticals (JAZZ) at Buy
StreetInsider
Daniel Busb
RBC Capital
176 USD
Upside 38%
6 months ago
May 2, 2024
Jazz Pharmaceuticals (JAZZ) PT Lowered to $176 at RBC Capital
StreetInsider
David Amsellem
Piper Sandler
188 USD
Upside 47%
7 months ago
Mar 20, 2024
Jazz Pharmaceuticals (JAZZ) PT Raised to $188 at Piper Sandler
StreetInsider
Daniel Busb
RBC Capital
Price Target 179 USD
Upside/Downside 40%
View Source
Annabel Samimy
Stifel Nicolaus
Price Target 230 USD
Upside/Downside 80%
View Source
Andrea Tan
Goldman Sachs
Price Target 169 USD
Upside/Downside 32%
View Source
Daniel Busb
RBC Capital
Price Target 176 USD
Upside/Downside 38%
View Source
David Amsellem
Piper Sandler
Price Target 188 USD
Upside/Downside 47%
View Source
Jazz Pharmaceuticals PLC Competitors:
Price Targets
VY4
SNDL Inc
81% Upside
4528
Ono Pharmaceutical Co Ltd
23% Upside
2005
SSY Group Ltd
40% Upside
MYX
Mayne Pharma Group Ltd
27% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
32% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
11% Upside
512
Grand Pharmaceutical Group Ltd
14% Upside
ANCR
Animalcare Group PLC
32% Upside

Revenue
Forecast

Revenue Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 14%. The projected CAGR for the next 3 years is 6%.

14%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 3%. The projected CAGR for the next 3 years is 42%.

3%
Past Growth
42%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 3%. The projected CAGR for the next 3 years is 51%.

3%
Past Growth
51%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAZZ's stock price target?
Price Target
182.28 USD

According to Wall Street analysts, the average 1-year price target for JAZZ is 182.28 USD with a low forecast of 121.2 USD and a high forecast of 241.5 USD.

What is Jazz Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 14%. The projected CAGR for the next 3 years is 6%.

What is Jazz Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
42%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 3%. The projected CAGR for the next 3 years is 42%.

What is Jazz Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
51%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 3%. The projected CAGR for the next 3 years is 51%.

Back to Top